KLK6 and atrial fibrillation: In the xenograft model using KLK6-overexpressing cells treated with AF alone or with AF plus CQ, we observed that the chemoresistance of KLK6-overexpressing cells was inhibited by combining AF treatment with CQ, indicating that inhibition of autophagy attenuates AF-induced chemoresistance via increased KLK6 levels.